Jane Street Group, LLC Krystal Biotech, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$174.7 - $213.66 $9.56 Million - $11.7 Million
54,700 New
54,700 $9.95 Million
Q1 2022

May 17, 2022
SELL
$51.99 - $72.11 $2.82 Million - $3.92 Million
-54,300 Reduced 91.11%
5,300 $353,000
Q4 2021

Feb 15, 2022
BUY
$39.81 - $88.24 $2.37 Million - $5.26 Million
59,600 New
59,600 $4.17 Million

Others Institutions Holding KRYS

# of Institutions
310
Shares Held
24.3M
Call Options Held
483K
Put Options Held
364K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.23B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email